Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Better Therapeutics Inc
(NQ:
BTTX
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Mar 15, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Better Therapeutics Inc
< Previous
1
2
3
4
5
6
7
8
Next >
Dow Jumps Over 100 Points; US Small Business Optimism Index Tops Estimates
July 11, 2023
U.S. stocks traded higher this morning, with the Dow Jones gaining over 100 points on Tuesday. Following the market opening Tuesday, the Dow traded up 0.40% to 34,080.13 while the NASDAQ rose 0.23% to...
Via
Benzinga
Why Are Better Therapeutics Shares Gaining Today?
July 11, 2023
Better Therapeutics Inc (NASDAQ: BTTX) shares are trading higher after the FDA approved the company's AspyreRx (formerly BT-001), a prescription-only digital treatment to provide cognitive behavioral...
Via
Benzinga
Why Is Iovance Biotherapeutics (IOVA) Stock Down 10% Today?
July 11, 2023
Iovance Biotherapeutics (IOVA) stock is sliding lower on Tuesday after the company announced details of a public share offering.
Via
InvestorPlace
Why Is EzFill (EZFL) Stock Down 5% Today?
July 11, 2023
EzFill (EZFL) stock is taking a beating on Tuesday despite the company releasing positive data from the second quarter of 2023.
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
July 11, 2023
Via
Benzinga
Better Therapeutics: Q1 Earnings Insights
May 11, 2023
Via
Benzinga
Better Therapeutics's Earnings: A Preview
May 10, 2023
Via
Benzinga
A Preview Of Better Therapeutics's Earnings
March 29, 2023
Via
Benzinga
Why Is Better Therapeutics (BTTX) Stock Up 39% Today?
July 11, 2023
Better Therapeutics (BTTX) stock is taking off on Tuesday as investors react to approval from the FDA for a Type 2 diabetes treatment.
Via
InvestorPlace
Why Better Therapeutics Are Trading Higher By 51%; Here Are 20 Stocks Moving Premarket
July 11, 2023
Gainers CytoMed Therapeutics Limited (NASDAQ: GDTC) shares surged 109.2% to $7.30 in pre-market trading after gaining 9% on Monday.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
July 11, 2023
It's time for another breakdown of the biggest pre-market stock movers as we check out all of the shares rising and falling on Tuesday!
Via
InvestorPlace
Better Therapeutics Receives FDA Authorization for AspyreRx™ to Treat Adults with Type 2 Diabetes
July 10, 2023
From
Better Therapeutics, Inc.
Via
Business Wire
Better Therapeutics Announces Upcoming Poster Presentation at EASL Congress 2023 in Vienna, Austria
June 16, 2023
From
Better Therapeutics, Inc.
Via
Business Wire
Better Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Updates
May 11, 2023
From
Better Therapeutics, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Monday's Intraday Session
May 08, 2023
Via
Benzinga
Better Therapeutics to Release First Quarter 2023 Financial Results and Provide Business Update on May 11, 2023
May 04, 2023
From
Better Therapeutics, Inc.
Via
Business Wire
Why Tupperware Brands Shares Are Trading Lower By Over 40%? Here Are Other Stocks Moving In Monday's Mid-Day Session
April 10, 2023
Gainers PLx Pharma Inc. (NASDAQ: PLXP) gained 128.2% to $0.2399 after dropping over 13% on Thursday.
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
April 07, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
April 07, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
April 06, 2023
Via
Benzinga
Better Therapeutics Announces $6.5MM Private Placement
April 06, 2023
From
Better Therapeutics, Inc.
Via
Business Wire
Why Bed Bath & Beyond Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
March 30, 2023
Gainers SCYNEXIS, Inc. (NASDAQ: SCYX) shares climbed 68% to $2.8184 after the company announced an exclusive license agreement with GSK for Brexafemme, in which the company will receive an upfront...
Via
Benzinga
Better Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Updates
March 30, 2023
From
Better Therapeutics, Inc.
Via
Business Wire
Better Therapeutics to Release Fourth Quarter and Full Year 2022 Financial Results and Provide Business Update on March 30, 2023
March 23, 2023
From
Better Therapeutics, Inc.
Via
Business Wire
Better Therapeutics to Participate in Two Upcoming Investor Conferences
February 09, 2023
From
Better Therapeutics, Inc.
Via
Business Wire
Better Therapeutics Posts Encouraging Data Establishing Proof-Of-Concept For Prescription Digital Therapy Platform
December 08, 2022
Via
Benzinga
Better Therapeutics Completes Exploratory Trial for Fatty Liver Disease and Announces Positive Topline Results
December 08, 2022
From
Better Therapeutics, Inc.
Via
Business Wire
Better Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 02, 2022
From
Better Therapeutics, Inc.
Via
Business Wire
Better Therapeutics to Participate in BTIG Digital Health Forum
November 15, 2022
From
Better Therapeutics, Inc.
Via
Business Wire
PDS Biotechnology To Rally Around 129%? Here Are 5 Other Price Target Changes For Tuesday
November 15, 2022
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.